| Pre-application—Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional)- PAR-21-342 |
X02
|
November 19, 2021 |
December 14, 2023 |
| Limited Competition—Research Resource for Human Organs and Tissues (U42 Clinical Trial Not Allowed)- PAR-22-056 |
U42
|
November 03, 2021 |
September 26, 2022 |
| Notice of Special Interest (NOSI)—Leveraging Microbial Exposure for Improving Mouse Models of Human Immunity- NOT-AI-21-072 |
R21
|
October 20, 2021 |
January 08, 2025 |
| Notice of Special Interest (NOSI)—Somatic Cell Gene Editing Therapies To Improve Transplantation Outcomes- NOT-AI-21-080 |
R21, R01
|
October 18, 2021 |
January 08, 2025 |
| Notice of Special Interest (NOSI)—Primary Caregiver Technical Assistance Supplements (PCTAS) (Admin Supp Clinical Trial Optional)- NOT-AI-21-074 |
Supp
|
September 24, 2021 |
September 24, 2024 |
| INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Exploratory/Developmental Research Grant Award (R21 Clinical Trial Not Allowed)- RFA-OD-21-007 |
R21
|
September 24, 2021 |
July 02, 2024 |
| Administrative Supplements To Promote Diversity in Research and Development Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)- PA-21-345 |
Supp
|
September 10, 2021 |
September 10, 2024 |
| Multipurpose Prevention Technology—Novel Systemic Options for Young Adults (R43/R44 Clinical Trial Not Allowed)- PAR-21-297 |
R43/R44
|
August 31, 2021 |
December 10, 2023 |
| Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award To Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)- PAR-21-271 |
K99/R00
|
August 17, 2021 |
September 08, 2024 |
| Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award To Promote Diversity (UE5 - Clinical Trial Not Allowed)- PAR-21-277 |
UE5
|
August 17, 2021 |
November 16, 2023 |
| Notice of Special Interest (NOSI)—Immune Responses to Arthropod Feeding on Vertebrate Hosts- NOT-AI-21-059 |
R01, R21
|
July 29, 2021 |
September 08, 2024 |
| Notice of Special Interest (NOSI)—Using the Collaborative Cross (CC) Mouse Model for Immunoregulatory and Infectious Disease Research- NOT-AI-21-071 |
R01, R21
|
July 29, 2021 |
September 08, 2024 |
| Notice of Special Interest (NOSI)—Research Supplements To Promote Re-Entry and Re-Integration into Health-Related Research Careers (Admin Supp - Clinical Trial Not Allowed)- NOT-OD-21-134 |
Supp
|
July 23, 2021 |
October 07, 2023 |
| Notice of Special Interest (NOSI)—Understanding the Immune Functions of DEAD/H-box Helicases- NOT-AI-21-066 |
R21, R01
|
July 22, 2021 |
September 08, 2024 |
| Limited Competition Emergency Awards—Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed)- PAR-21-276 |
S10
|
July 16, 2021 |
July 16, 2022 |
| NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)- PAR-21-258 |
R25
|
July 16, 2021 |
September 08, 2023 |
| Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed)- PAR-21-247 |
R43/R44
|
July 12, 2021 |
June 16, 2023 |
| Pediatric Immune System–Ontogeny and Development (INTEND) (R01 Clinical Trial Not Allowed)- PAR-21-248 |
R01
|
July 09, 2021 |
May 08, 2024 |
| Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions (R01 Clinical Trial Not Allowed)- PAR-21-253 |
R01
|
July 06, 2021 |
October 20, 2023 |
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)- PA-21-268 |
|
June 30, 2021 |
July 01, 2024 |
| Support for Small Business Innovation Research (SBIR) to Develop New Methods and Technologies for Assessment of Risk and for Early Diagnosis and Prognosis of Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed)- RFA-DK-21-021 |
R43/R44
|
June 25, 2021 |
October 08, 2022 |
| CCRP Initiative—Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms (R01 Clinical Trial Not Allowed)- RFA-ES-21-006 |
R01
|
June 25, 2021 |
September 21, 2023 |
| Notice of Special Interest (NOSI) HIV/AIDS in the Era of COVID-19— When Pandemics Collide- NOT-AI-21-057 |
R01, R21
|
June 25, 2021 |
May 08, 2024 |
| Notice of Special Interest (NOSI)—Harnessing Big Data To Halt HIV- NOT-AI-21-054 |
R01
|
June 22, 2021 |
May 08, 2024 |
| Notice of Special Interest (NOSI)— HIV Drug Resistance Assays and Actionable Data Dissemination Strategies- NOT-AI-21-056 |
Multiple |
June 17, 2021 |
May 08, 2024 |
